Clinical Trial Update: A Study of ZT002 Injection in Participants With Overweight or Obesity [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ZT002 injection in adults with overweight or obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ZT002

Snippet

Sponsor: Beijing QL Biopharmaceutical Co.,Ltd | Conditions: Overweight or Obesity | Phase 1 | Status: COMPLETED